Original Article

Identification of Key Carcinogenic Genes in Colon Adenocarcinoma

Abstract

Background: We aimed to probe carcinogenic genes associated with colon adenocarcinoma (COAD) development.

Methods: The gene expression profile of COAD were downloaded from TCGA. Differentially expressed genes (DEGs) were identified; GO and KEGG pathway enrichment were analyzed. Applying the up-mRNA-and-down-miRNA pairs and the down-mRNA-and-up-miRNA pairs, the miRNA target network was generated. The important genes were further analyzed towards the influence on overall survival and immune infiltration. In addition, essential miRNAs were selected for expression validation using real-time qPCR.

Results: Together, from 2020-2021, in Central Laboratory of the Second Affiliated Hospital of Fujian Medical University, we found 3060 up-regulated transcripts and 2254 down-regulated transcripts in mRNA expression, with 235 up-regulated and 263 down-regulated miRNAs. We discovered 98 enriched GO terms using the upregulated DEGs and 315 enriched GO terms using downregulated DEGs. There were 14 enriched KEGG pathways based on the down-regulated DEGs and only one pathway based on the up-regulated DEGs. There were 61 up-mRNA-and-down-miRNA pairs, including 7 miRNAs and 41 carcinogenic targets, among which HOXC13, FOXL2NB, ALOXE3, and ZIC2 were found related to a poorer OS. ZIC2 located at the subnet with the most targets (the miR-129-5p subnet). ZIC2 expression was correlated with immune-cell infiltration.

Conclusion: These risk genes, interaction networks, and enrichments may provide a better understanding of the complex molecular mechanisms in COAD development and potential therapeutic targets for clinical treatment of COAD.

1. Termuhlen PM, Sweeney-Gotsch BM, Berman RS, et al (2002). Increased apoptosis in metastatic human colonic adenocarcinomas. Cancer Biol Ther, 1(1):58-63.
2. Yu D, Gao P, Song Y, et al (2018). The differences on efficacy of oxaliplatin in locally advanced colon cancer between mucinous and nonmucinous adenocarcinoma. Cancer Med, 7(3):600-615.
3. Chang Z, Huang R, Fu W, et al (2020). The Construction and Analysis of ceRNA Network and Patterns of Immune Infiltration in Colon Adenocarcinoma Metastasis. Front Cell Dev Biol, 8:688.
4. Chen C, Huang H, Wu CH (2017). Protein Bioinformatics Databases and Resources. Methods Mol Biol, 1558:3-39.
5. Bhattacharya S, Dunn P, Thomas CG, et al (2018). ImmPort, toward repurposing of open access immunological assay data for translational and clinical research. Sci Data, 5:180015.
6. Li B, Severson E, Pignon JC, et al (2016). Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol, 17(1):174.
7. Xu Z, Zheng J, Chen Z, et al (2021). Multilevel regulation of Wnt signaling by Zic2 in colon cancer due to mutation of β-catenin. Cell Death Dis, 12(6):584.
8. Jeong E, Lee Y, Kim Y, Lee J, Yoon S (2020). Analysis of Cross-Association between mRNA Expression and RNAi Efficacy for Predictive Target Discovery in Colon Cancers. Cancers (Basel), 12(11):3091
9. Zhang JX, Song W, Chen ZH, et al (2013). Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. Lancet Oncol, 14(13):1295-1306.
10. Lu JH, Zuo ZX, Wang W, et al (2018). A two-microRNA-based signature predicts first-line chemotherapy outcomes in advanced colorectal cancer patients. Cell Death Discov, 4:116.
11. Wu Q, Meng WY, Jie Y, Zhao H (2018). LncRNA MALAT1 induces colon cancer development by regulating miR-129-5p/HMGB1 axis. J Cell Physiol, 233(9):6750-6757.
12. Hu D, Zhang B, Yu M, Shi W, Zhang L (2020). Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network. Mol Med Rep, 22(2):620-632.
13. Xi G, Ziyu X, Yiting L, Zonghang L, Lifeng Z (2021). Construction of competing endogenous RNA network and identification of novel molecular biomarkers in colon cancer: A bioinformatic analysis. Medicine (Baltimore), 100(14):e25369.
14. Li C, Cui J, Zou L, Zhu L, Wei W (2020). Bioinformatics analysis of the expression of HOXC13 and its role in the prognosis of breast cancer. Oncol Lett, 19(1):899-907.
15. Ruan GT, Gong YZ, Zhu LC, et al (2020). The Perspective of Diagnostic and Prognostic Values of Lipoxygenases mRNA Expression in Colon Adenocarcinoma. Onco Targets Ther, 13:9389-9405.
Files
IssueVol 51 No 2 (2022) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijph.v51i2.8689
Keywords
Colon cancer Database Carcinogenic gene Bioinformatics analysis
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Dai Y, Jiang Z, Qiu Y, Kang Y, Xu H, Xu T. Identification of Key Carcinogenic Genes in Colon Adenocarcinoma. Iran J Public Health. 2022;51(2):364-374.